Transforming growth factor β signaling, vascular remodeling, and hypertension

New England Journal of Medicine

Volumn 354, Issue 25, 2006, Pages

  August, Phyllis ^a,b   Suthanthiran, Manikkam ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMILIN 1; FURIN; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CELL FUNCTION; DISEASE COURSE; FIBROSIS; HEART OUTPUT; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE REPAIR; VASCULAR RESISTANCE; VASCULAR TISSUE; VASOCONSTRICTION;

ANIMALS; ARTERIES; BLOOD PRESSURE; HUMANS; HYPERTENSION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; XENOPUS LAEVIS;

EID: 33745243399     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr062143     Document Type: Short Survey

References (5)

1. Zacchigna L, Vecchione C, Notte A, et al. Emilin1 links TGFbeta maturation to blood pressure homeostasis. Cell 2006;124:929-42.
2. Suthanthiran M, Li B, Song JO, et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 2000;97:3479-84.
3. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. Hypertension 1996;28:881-7.
4. Lavoie P, Robitaille G, Agharazii M, Ledbetter S, Lebel M, Lariviere R. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J Hypertens 2005;23:1895-903.
5. Border WA, Noble NA. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998;31:181-8.